Chapter I Reform of Medical and Health System
Test site summary
On April 6th, 2009, "Opinions of Central the State Council on Deepening the Reform of Medical and Health System" was issued, which marked that China's medical and health system entered the stage of deepening reform and a new round of medical reform was officially launched.
2. Basic principles: ① Adhere to the people-oriented principle and give priority to safeguarding people's health rights and interests; ② Insist on the national conditions and establish a medical and health system with China characteristics; Adhere to the unity of fairness and efficiency, and combine the leading role of the government with the role of the market mechanism; ④ Insist on overall consideration and combine solving current outstanding problems with improving the system.
3. Overall goal: establish and improve the basic medical and health system covering urban and rural residents, and provide safe, effective, convenient and cheap medical and health services for the masses.
4. Main contents of the basic medical and health system: The basic medical and health system is mainly composed of four medical and health systems and eight supports. The four systems refer to the construction of public health service system, medical service system, medical security system and drug supply security system, as well as the construction of basic medical and health system in China.
5. Drug supply guarantee system requirements: accelerate the establishment of a drug supply guarantee system based on the national essential drug system to ensure the safety of people's medication; Contents: ① Establish the national essential drug system, ② standardize the production and circulation of drugs, and ③ improve the drug reserve system.
6. The main contents of the five key reforms in the implementation plan are "four basics" and "one pilot", namely, accelerating the construction of the basic medical security system, initially establishing the national basic drug system, improving the primary medical and health service system, promoting the gradual equalization of basic public health services, and promoting the pilot reform of public hospitals.
7. Talent guarantee mechanism of medical and health system reform: ① Strengthen the construction of medical and health talent team. ② Give full play to the role of licensed pharmacists: The opinions of the Central Committee and the State Council on deepening the reform of medical and health system emphasize: standardize clinical medication and give full play to the role of licensed pharmacists in guiding rational drug use and drug quality management; The recent key implementation plan of medical and health system reform (2009-20 1 1) issued by the State Council further clarifies that to improve the licensed pharmacist system, retail pharmacies must be equipped with licensed pharmacists to provide patients with consultation and guidance on drug purchase.
8. Provisions on quality supervision and management of essential drugs: The State Food and Drug Administration of the United States is responsible for the evaluation and sampling of essential drugs, increasing the sampling proportion of essential drugs in the annual drug sampling plan, organizing the re-evaluation of essential drug varieties, and informing the Ministry of Health of the re-evaluation results in a timely manner; Provincial food and drug supervision departments are responsible for the supervisory sampling inspection of essential drugs, organize no less than two routine inspections every year, and at least conduct a sampling inspection of essential drugs produced by essential drug production enterprises within their respective jurisdictions; Local food and drug administrations at all levels should further strengthen the quality supervision and management of essential drugs in urban communities and rural areas, and give full play to the role of rural drug supervision network in ensuring the quality supervision and management of essential drugs.
9. Provisions on the retail guidance price of national essential drugs: The retail guidance price of national essential drugs is formulated according to the generic name of the drug, regardless of the specific production and operation enterprises. Medical and health institutions at all levels, social retail pharmacies and related drug production and business units can independently determine prices according to market supply and demand under the premise of not exceeding retail guidance prices.
10. Main contents of reforming the drug price formation mechanism: The competent pricing department of the State Council is responsible for setting the prices of national essential drugs, prescription drugs used in national basic medical insurance and special drugs with monopoly position in production and operation. The competent price departments of all provinces, autonomous regions and municipalities directly under the Central Government are responsible for setting the prices of non-prescription drugs (excluding national essential drugs) in the national basic medical insurance drugs and local supplementary medical insurance drugs according to the unified national policies. The prices of pharmaceutical preparations prepared by non-profit medical institutions shall be determined by provinces, autonomous regions and municipalities directly under the Central Government according to local actual conditions, and the authority, form and content of price management shall be determined. The government sets drug prices. Generally, the specific production and operation enterprises are not distinguished, and unified guidance prices are formulated according to the generic names of drugs. If there is a big price difference between the price set by a specific enterprise and the unified guidance price, it is necessary to intensify the adjustment and gradually narrow the price difference. In the future, different pricing policies can be implemented for drugs that meet the national policy of encouraging and supporting development and have obviously different quality standards in accordance with the principle of quality pricing.
Chapter II Pharmaceutical Affairs Management System
Test site summary
1. Division of responsibilities between competent departments and relevant administrative departments
(1) competent department: drug supervision and administration department-the State Council drug supervision and administration department is in charge of the national drug supervision and administration work; The pharmaceutical supervisory and administrative departments of the people's governments of provinces, autonomous regions and municipalities directly under the Central Government shall be responsible for the pharmaceutical supervisory and administrative work within their respective administrative areas. The drug supervision and administration department of the State Council shall cooperate with the comprehensive economic department of the State Council to implement the development plan and industrial policy of the pharmaceutical industry formulated by the state.
(2) Health administrative department: the Ministry of Health "manages the State Food and Drug Administration and state administration of traditional chinese medicine"; Responsible for formulating laws and regulations on drugs and medical devices, and formulating relevant standards and technical specifications according to law; To be responsible for establishing the national essential drug system and formulating the national drug policy; Responsible for the development planning of traditional Chinese medicine; To be responsible for approving and revoking the practice certificate of medical institutions; Responsible for the management of narcotic drugs and psychotropic drugs in medical institutions; To be responsible for the management of adverse drug reaction reporting system in medical institutions and participate in the management of clinical trials of drugs and medical devices; Responsible for the management and supervision of the use of pharmacies, drugs and medical devices in medical institutions, guide and manage the rational clinical use of drugs in medical institutions, and standardize prescription behavior.
(3) state administration of traditional chinese medicine: Responsible for formulating development plans and policies for traditional Chinese medicine and ethnic medicine.
(4) National Development and Reform Macro-control Department: responsible for the macro-economic monitoring and management of drugs; Responsible for the supervision and management of drug prices.
(5) Human resources and social security departments: co-ordinate the establishment of a social security system covering urban and rural areas. Responsible for organizing the formulation of the management, settlement methods and payment scope of medical insurance services and maternity insurance services of designated medical institutions and pharmacies, including the formulation and publication of the national drug list of basic medical insurance, industrial injury insurance and maternity insurance.
(six) the administrative department for industry and commerce: responsible for the industrial and commercial registration of pharmaceutical production and marketing enterprises, and investigate and deal with the unlicensed production and marketing of drugs; Responsible for the supervision of drug advertisements and punishing the publishing of false and illegal drug advertisements; Responsible for the supervision and management of drug market transactions and online commodity transactions, including the operation of Chinese herbal medicines in urban and rural markets.
(7) Ministry of Industry and Information Management: responsible for formulating and implementing plans, policies and standards for the biopharmaceutical industry; To undertake the management of pharmaceutical industry; Responsible for the management of national drug reserves.
(VIII) Business Management Department: as the management department of the pharmaceutical circulation industry, it is responsible for studying and formulating the development plan, industry standards and relevant policies of the pharmaceutical circulation industry, and cooperating with the implementation of the national essential drug system.
(9) Customs: responsible for setting up drug import and export ports.
(10) Public security department: responsible for accepting and investigating drug criminal cases; Cooperate with the drug regulatory authorities to crack down on illegal acts of producing, selling and using counterfeit and inferior drugs and related narcotic drugs and psychotropic drugs.
(1 1) Regulatory department: responsible for investigating and dealing with violations of administrative discipline by pharmaceutical supervisory and administrative personnel.
2. Functions of the state drug supervision and administration department: ① Legislation: formulate policies, plans, quality management norms and other relevant legislation on safety supervision and management of "three products and one device" (drugs, medical devices, cosmetics and food in consumption) and supervise their implementation; (two) responsible for the administrative supervision and technical supervision of drugs and medical devices; ③ Responsible for the supervision and management of registration of drugs and medical devices, monitoring of adverse drug reactions and post-marketing re-evaluation; (4) Responsible for food hygiene licensing and food safety supervision and management in consumption; ⑤ Responsible for cosmetics hygiene license, hygiene supervision and management, and cosmetics examination and approval; ⑥ Participate in the formulation of the national essential drugs list, cooperate with relevant departments to implement the national essential drugs system, and organize the implementation of the classified management system for prescription drugs and over-the-counter drugs; ⑦ Formulate and improve the qualification system of licensed pharmacists, and guide and supervise the registration of licensed pharmacists.
3. Internal institutions
(1) China Institute for the Control of Pharmaceutical and Biological Products
(2) National Pharmacopoeia Committee
(three) the main responsibilities of the drug evaluation center, the drug evaluation center, the drug certification management center, the licensed pharmacist qualification certification center, and the National Traditional Chinese Medicine Variety Protection Review Committee.
3. Drug supervision and management system below the provincial level: On June 2008 1 10, the General Office of the State Council issued the Notice on Issues Related to Adjusting the Food and Drug Supervision and Management System below the provincial level (Guo Ban Fa [2008]123), which stipulated that the vertical management of the current food and drug supervision and management institutions below the provincial level should be changed to the hierarchical management of local governments. Provincial food and drug supervision and management institutions, as the working bodies of provincial governments, are managed by health departments at the same level. As the working body of the government at the same level, the food and drug supervision and management institutions in cities and counties ensure that they perform their duties relatively independently according to law and effectively supervise the whole process of food safety and drug research, production, circulation and use in consumption.
4. Drug technical supervision and management institutions
(1) China Institute for the Control of Pharmaceutical and Biological Products: China Institute for the Control of Pharmaceutical and Biological Products is a public institution directly under the US Food and Drug Administration, and is the national legal institution for testing the quality of pharmaceutical and biological products. (a) to undertake the inspection and re-inspection required for drug approval and quality supervision and inspection according to law. (2) Responsible for the calibration and management of national drug standards and reference substances. (3) Entrusted by the State Food and Drug Administration of the United States, undertake the specific business work of batch issuance of biological products. (four) to undertake the technical appraisal of the drug content and impurity components of counterfeit drugs suspected of "endangering human health" entrusted by judicial institutions.
(2) National Pharmacopoeia Committee: ① China Pharmacopoeia and its supplements. (two) to organize the formulation and revision of national drug standards and medical requirements and standards for packaging materials, containers and pharmaceutical excipients that are in direct contact with drugs.
(3) National Drug Evaluation Center of US Food and Drug Administration: a technical evaluation institution for drug registration, which provides technical support for drug registration.
(4) National Drug Evaluation Center of US Food and Drug Administration: the brand of "National Adverse Drug Reaction Monitoring Center" was added. (a) to undertake the technical work of the formulation and adjustment of the national essential drugs list and its related business organizations. (two) to undertake the technical work of formulating and adjusting the catalogue of over-the-counter drugs and related business organizations. (3) To undertake the technical work of drug re-evaluation and drug elimination and relevant business organizations. (four) to undertake the technical work of the national adverse drug reaction monitoring and related business organizations, and provide technical guidance to the adverse drug reaction monitoring centers of provinces, autonomous regions and municipalities directly under the central government.
(5) National Drug Certification Management Center of US Food and Drug Administration: ① Participate in the formulation and revision of Quality Management Standards for Non-clinical Research of Drugs (GLP), Quality Management Standards for Clinical Trials of Drugs (GCP), good manufacturing practice (GMP), Quality Management Standards for Production of Chinese Herbal Medicines (GAP), Quality Management Standards for Pharmaceutical Trading (GSP) and Quality Management Standards for Production of Medical Devices. ② Conduct on-site inspection of drugs, medical device manufacturers, GAP certification enterprises (units) and medical institutions recognized by GCP that apply for GMP certification from the State Food and Drug Administration.
(6) National Licensed Pharmacist Certification Center of the US Food and Drug Administration: ① Undertaking professional and technical business organization work such as licensed pharmacist qualification examination, registration and continuing education.
(7) National Evaluation Committee for Variety Protection of Traditional Chinese Medicine (Health Food Evaluation Center of US Food and Drug Administration): one institution and two brands.
Chapter III Drug Quality and Its Supervision and Inspection
Test site summary
1. Definition and scope of application of national drug code: On June 16, 2009, the State Food and Drug Administration of the United States issued the Notice on Implementing National Drug Code Management (hereinafter referred to as the Notice) to implement code management for drugs approved for marketing. National drug code refers to the coded identification used by computers to express specific information in the process of drug research and development, production, management, use and supervision. The national drug code is expressed in the form of numbers or the combination of numbers and letters, which is suitable for information construction, information processing and information exchange in various fields such as drug research, production, management, use and supervision, as well as e-government and e-commerce.
2. Compilation principles and classification: Drug codes are divided into standard codes, supervision codes and classification codes. The standard code consists of drug country code, drug category code, drug ontology code and check code.
3. Compilation rules of standard code: The standard code of drug code is ***l4, which is composed of drug country code, drug category code, drug ontology code and check code in turn, leaving no spaces. The first two are drugs with country code "86", which represent all drugs produced and sold in China; The third drug category code is "9", which stands for drugs; Numbers from 4 to 13 are ontology codes, and the first 5 digits of ontology codes are pharmaceutical enterprise logos. According to the Business License of Enterprise as a Legal Person and the Pharmaceutical Production License, it is compiled according to the principle of one license and one photo. The last five digits of ontology code are drug identification, which refers to all drugs owned by enterprises determined by the first five digits. Drug product identification shall be compiled in line with the drug approval number, drug name, dosage form and specifications, following the principle of one thing and one yard. The check code is the last character of the national drug coding standard code. The correctness of the first 13 bits in the national drug coding standard code is verified by a specific mathematical formula.
Part II Provisions on Administration of Pharmaceutical Affairs
Interpretation of the Supreme People's Court and the Supreme People's Procuratorate on Several Issues Concerning the Specific Application of Laws in Handling Criminal Cases of Producing and Selling Fake Drugs and Inferior Drugs
Test site summary
Article 1 The production and sale of counterfeit drugs shall be deemed as "enough to seriously endanger human health" as stipulated in Article 141 of the Criminal Law under any of the following circumstances:
(a) according to the national drug standards should not contain toxic and harmful substances, but contain toxic and harmful substances, or contain substances that exceed the provisions of the national drug standards;
(2) Belonging to narcotic drugs, psychotropic drugs, toxic drugs for medical use, radioactive drugs, birth control pills, blood products or vaccines;
(three) pregnant women, infants, children or critically ill patients as the main object of use;
(4) It belongs to injection drugs and emergency drugs;
(five) no or forged drug production license or approval number, and it belongs to prescription drugs;
(6) Other circumstances that seriously endanger human health.
If it is difficult to determine the circumstances specified in items (1) and (6) of the preceding paragraph, it may entrust a drug inspection agency set up or determined by the drug supervision and administration department at or above the provincial level for inspection.
Article 2 A counterfeit drug produced or sold after use causes minor injuries or slight or moderate disabilities, or organ or tissue damage causes general or serious dysfunction, or there are other situations that seriously endanger human health, which shall be deemed as "causing serious harm to human health" as stipulated in Article 141 of the Criminal Law.
If the use of fake drugs produced and sold causes severe disability, three or more serious injuries, three or more moderate disabilities, or serious dysfunction caused by organ or tissue damage, ten or more minor injuries, five or more slight disabilities, or general dysfunction caused by organ or tissue damage, or other situations that are particularly harmful to human health, it shall be deemed as "particularly harmful to human health" as stipulated in Article 141 of the Criminal Law.
Article 3 If the inferior drugs produced and sold cause minor injuries or slight or moderate disabilities after use, or organs and tissues are damaged to cause general or serious dysfunction, or there are other situations that seriously endanger human health, it shall be deemed as "causing serious harm to human health" as stipulated in Article 142 of the Criminal Law.
If the use of inferior drugs produced and sold causes death, severe disability, serious injury of more than three people, moderate disability of more than three people, serious dysfunction caused by organ and tissue damage, minor injury of more than ten people, mild disability of more than five people or general dysfunction caused by organ and tissue damage, or causes other particularly serious harm to human health, it shall be deemed as "especially serious consequences" as stipulated in Article 142 of the Criminal Law.
Article 4 If a medical institution knows or should know that it is a counterfeit drug and uses or sells it, which meets the standards stipulated in Article 1 or Article 2 of this Interpretation, it shall be investigated for criminal responsibility for the crime of selling counterfeit drugs.
If a medical institution uses or sells drugs that it knows or should know are inferior drugs, which meets the standards stipulated in Article 3 of this Interpretation, it shall be investigated for criminal responsibility for the crime of inferior drugs.
Article 5 Whoever knows or should know that others are producing and selling counterfeit drugs and inferior drugs, but under any of the following circumstances, shall be punished as the crime of producing and selling counterfeit drugs or the crime of producing and selling inferior drugs:
(1) Providing funds, loans, account numbers, invoices, certificates and licenses;
(2) Providing production and business premises, equipment or transportation, warehousing, storage, mailing and other facilities;
(3) Providing production technology, or providing raw materials, auxiliary materials and packaging materials;
(4) Providing advertisements and other publicity.
Article 6 Whoever commits the crime of producing and selling fake and inferior drugs, and at the same time constitutes the crime of producing and selling fake and inferior products, the crime of infringing intellectual property rights, the crime of illegal business operation, the crime of illegal medical practice, and the crime of illegal blood collection and blood supply. , convicted and punished in accordance with the provisions of heavier punishment.
Article 7 During natural disasters, accidents, public health incidents, social security incidents and other emergencies, those who produce and sell counterfeit drugs and inferior drugs to deal with emergencies shall be severely punished according to law.
Implementation Opinions on Establishing National Essential Drug System
Test site summary
1. Definition of essential drugs and essential drug system: Essential drugs refer to drugs that meet basic medical and health needs, have appropriate dosage forms, are reasonably priced, can guarantee supply, and can be obtained fairly by the public. All primary medical and health institutions organized by the government are equipped with and use essential drugs, and other medical institutions must also use essential drugs according to regulations. The national essential drug system is a system that effectively manages the selection, production, circulation, use, pricing, reimbursement, monitoring and evaluation of essential drugs, and is connected with public health, medical services and medical security systems.
2. Functions of the National Essential Medicines Working Committee: The National Essential Medicines Working Committee is responsible for coordinating and solving relevant policy issues in all aspects of the formulation and implementation of the national essential medicines system, determining the framework of the national essential medicines system, determining the principles, scope, procedures and work plans for the selection and adjustment of the national essential medicines list, and reviewing the national essential medicines list.
3. Provisions on the use and sale of essential drugs: In counties (cities, districts) where the basic drug system is implemented, the basic drugs equipped and used by grass-roots medical and health institutions organized by the government are sold at a zero rate; Establish a system of priority use and rational use of essential drugs; All primary medical and health institutions organized by the government are equipped with and use national essential drugs; Other types of medical institutions should also take essential drugs as the first choice and reach a certain proportion of use, and the specific proportion of use shall be determined by the health administrative department; Medical institutions shall, in accordance with the national guidelines for clinical application of essential drugs and the prescription set of essential drugs, strengthen the management of rational drug use and ensure the standardized use of essential drugs; Patients can buy medicines at retail pharmacies with prescriptions. Retail pharmacies must be equipped with licensed pharmacists or other qualified pharmaceutical technicians according to law, provide consultation and guidance on drug purchase for patients, review the legality and rationality of prescriptions, and correctly allocate and sell drugs according to prescriptions.
4. Provisions on reimbursement of essential drugs: All essential drugs are included in the basic medical insurance drug reimbursement catalogue, and the reimbursement ratio is significantly higher than that of non-essential drugs.
Measures for the Administration of National Essential Drugs List (Provisional)
Test site summary
1. Classification basis of drugs in the National Essential Drugs List: Drugs in the National Essential Drugs List include chemicals, biological products and Chinese patent medicines. Chemicals and biological products are mainly classified according to clinical pharmacology, while Chinese patent medicines are mainly classified according to functions.
2. Selection principle and dynamic management of national essential drugs: The selection of national essential drugs should be based on the principles of prevention and control necessity, safety and effectiveness, reasonable price, convenient use, equal emphasis on Chinese and western medicines, basic guarantee, clinical preference and grassroots availability, combined with the characteristics of drug use in China and referring to international experience, and reasonably determine the variety (dosage form) and quantity.
3. Drug requirements for inclusion in the National Essential Drugs List: The chemicals, biological products and proprietary Chinese medicines in the National Essential Drugs List should be the varieties recorded in the Pharmacopoeia of People's Republic of China (PRC) and the drug standards promulgated by the Ministry of Health and the State Food and Drug Administration of the United States. In addition to first-aid and rescue drugs, the national essential drugs list of exclusive production varieties should be independently demonstrated. The names of chemicals and biological products are chemical components represented by Chinese common names and English international common drug names, and the dosage forms are listed separately; Chinese patent medicines adopt generic names.
4. It cannot be included in the selection scope of the National Essential Drugs List: the following drugs are not included in the selection scope of the National Essential Drugs List: ① drugs containing endangered wild animals and plants; ② It is mainly used for nourishing and health care, and is easy to be abused; ③ Not the first choice for clinical treatment; (4) Due to serious adverse reactions, the State Food and Drug Administration of the United States has explicitly stipulated that production, sale or use should be suspended; (five) in violation of national laws and regulations, or does not meet the moral requirements; ⑥ Other circumstances stipulated by the National Essential Drugs Working Committee.
5. Transfer from the national essential drugs list: varieties that fall into one of the following circumstances are transferred from the national essential drugs list: ① drug standards have been cancelled; ② The State Food and Drug Administration revoked its drug approval certificate; ③ Serious adverse reactions; According to pharmacoeconomic evaluation, it can be replaced by varieties with better risk-benefit ratio or cost-benefit ratio; ⑤ Other circumstances that the National Essential Drugs Working Committee thinks should be transferred out.
Part III Pharmaceutical Professional Ethics
Chapter I Professional Ethics of Licensed Pharmacists in China
Test site summary
First, to heal the wounded and rescue the dying, do not disgrace the mission: when licensing drugs, we should give priority to the health and life safety of patients and the public, and provide drugs and pharmaceutical services to patients and the public with our professional knowledge, skills and conscience.
Second, respect patients and treat them equally: licensed pharmacists should respect the values, right to know, autonomy and privacy of patients or consumers, and treat patients or consumers equally, regardless of age, gender, nationality, belief, occupation, status and wealth.
Third, practice according to law, quality first: licensed pharmacists should abide by the laws and regulations on drug management, abide by professional ethics, practice independently according to law, ensure the quality of drugs and pharmaceutical services, scientifically guide drug use, and ensure the safety, effectiveness, economy and appropriateness of public drug use.
Fourth, study in Germany and cherish the reputation: licensed pharmacists should constantly learn new knowledge and technology, strengthen moral cultivation, and improve their professional level and practical ability; Know the shame of honor and honor, be honest and clean, consciously resist immoral behavior and illegal behavior, and strive to maintain professional reputation.
5. Respect colleagues and cooperate closely: licensed pharmacists should understand each other, trust each other, treat each other sincerely, cooperate closely, establish a harmonious working relationship, and make contributions to the development of pharmacy and human health.
Section 2 Application Guide of Professional Ethics of Licensed Pharmacists in China
1. Save the wounded and rescue the dying, do not disgrace the mission: licensed pharmacists should take safeguarding the life safety and health interests of patients and the public as the highest code of conduct; Every effort should be made to alleviate the pain of patients; In case of emergency endangering the life safety of patients and the public, necessary pharmaceutical services and rescue measures shall be provided; Provide high-quality drugs and pharmaceutical services for patients and the public.
2. Respect patients and treat patients equally: licensed pharmacists should dress in accordance with the regulations, wear the national uniform licensed pharmacist badge and badge indicating their name and position, and the licensed pharmacist registration certificate should be hung in a conspicuous and easy-to-see place in the pharmacy where they practice; Treat patients equally, without any discrimination or other immoral behavior; Respect the patient's privacy, and shall not disclose the patient's privacy known during the practice without reason; Licensed pharmacists shall not refuse to prepare prescriptions, provide drugs or pharmaceutical services for patients unless there are justified reasons; It should meet the needs of patients' medication consultation.
3. Practice according to law, quality first: licensed pharmacists should abide by the laws and regulations on drug management, ensure the quality of drugs and pharmaceutical services, and ensure the public's safe, effective, economical and rational use of drugs; Should be registered in accordance with the regulations, to participate in continuing education; It shall engage in legal pharmaceutical technology business activities in legal pharmaceutical retail enterprises and medical institutions, and shall not engage in commercial pharmaceutical retail business outside the practice place; Don't give your licensed pharmacist qualification certificate, licensed pharmacist registration certificate, emblem and badge to others or institutions for use; Not in the pharmaceutical retail enterprises and medical institutions in name only; Do not agree or instruct others to use their own names to sell drugs or provide pharmaceutical services to the public; Should be on the job and not practice in two or two fields at the same time; When leaving the practice place temporarily and there is no other licensed pharmacist to take over, there shall be a notice that the licensed pharmacist temporarily leaves and suspends the key pharmaceutical service business; It is necessary to accurately explain the drug instructions to patients, pay attention to explain the contraindications, adverse reactions, precautions and usage methods of drugs, and answer patients' medication questions in detail; Prescription drugs should be prepared and sold by doctors' prescriptions, and the prescriptions should be reviewed to confirm the legality and rationality of the prescriptions, and the drugs should be correctly prepared and sold according to the prescriptions after signing; Without authorization, the prescription shall not be changed or replaced beyond the statutory authority; Patients should be provided with medication guidance on the correct use of prescription drugs and the purchase and use of Class A non-prescription drugs; Give enthusiastic, patient, accurate and complete answers to patients' questions about the selection and use of Class B OTC drugs and other questions about drugs and health; For drugs used by children, pregnant women, the elderly and other special groups, or drugs with contraindications, serious adverse reactions or improper use may affect the curative effect and even endanger the health and life safety of patients, licensed pharmacists should require patients to use drugs in strict accordance with the provisions of the drug instructions, and give clear verbal reminders when giving drugs. ; To manage the quality of drugs and pharmaceutical services of practicing institutions according to law, organize the formulation and revision of management rules and regulations that can effectively guarantee the quality of drugs and pharmaceutical services, and supervise the implementation; To obviously endanger the patient's life safety or health, in violation of the law or social morality, should be rejected; Should be responsible for the quality of pharmaceutical services; Licensed pharmacists should correct incorrect prescription drug allocation, sales or services.
4. Studying in Germany and cherishing reputation: licensed pharmacists should actively receive continuing education and constantly improve their professional level; Go deep into communities and villages, provide a wide range of medicines and pharmaceutical services for urban and rural residents, and vigorously publicize and popularize safe medication and health care knowledge; We should abide by the industry competition norms, compete fairly, consciously maintain the practice order, and safeguard the professional honor and social image of licensed pharmacists; Do not solicit business by belittling the professional ability and level of peers; The badge is not printed with academic qualifications, academic qualifications, professional titles, social positions and honors; We should expose and resist unethical or dishonest behaviors involving any member in the medical field and behaviors that tarnish professional honor; Do not seek illegal interests with pharmaceutical production and trading enterprises and their business personnel, medical institutions and their doctors, nursing staff and other employees, and do not use the status of licensed pharmacists to carry out or participate in illegal business activities.
5. Respect colleagues and cooperate closely: licensed pharmacists should respect their peers, help each other in the same trade, compete fairly, improve their professional level, and must not slander or damage the prestige and reputation of other licensed pharmacists; We should strengthen the contact with medical staff and patients, actively participate in the formulation and revision of drug use plans, and provide professional and responsible pharmaceutical support; Understand each other, treat each other sincerely and cooperate closely with medical staff to establish a harmonious working relationship; In the event of a liability accident, we should distinguish our own responsibilities and not shirk each other.
So comprehensive and straight to the point! Be sure to give more points! ! !